Bayer OA Knee Pain Pilot

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Osteoarthritis, Knee
Interventions
DIAGNOSTIC_TEST

dynamic contrast enhanced MRI

An MRI study of the knee will be done to check the degree of osteoarthritis and blood flow to the affected knee. This scan will take about 1-2 hour(s).

PROCEDURE

geniculate artery embolization

The physician will perform a diagnostic angiography, where they will take pictures of vessels near the knee that will be treated. Once the artery to be treated is identified, the doctor will guide a thin wire called a microwire, and a plastic tube called a microcatheter to the targeted artery, and more pictures of vessels at the knee will be taken. This picture will be used to see if there are any abnormal vessels at the knee, such as abnormal blood flow, abnormal vessel connections (between the veins and arteries), or new blood vessel growth. Once the targeted artery at the knee is confirmed, the doctor will inject enough particle embolic (Embozene) to slow or stop the blood flow in the geniculate artery. Once all vessels are treated, a final angiogram (pictures of blood vessels) will be performed to ensure that the blood flow has slowed.

Trial Locations (1)

29425

RECRUITING

Medical University of South Carolina, Charleston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Medical University of South Carolina

OTHER

NCT05349682 - Bayer OA Knee Pain Pilot | Biotech Hunter | Biotech Hunter